| RS1458654786 |
KYNU
|
Health Risk |
Pathogenic |
Congenital NAD deficiency disorder, Vertebral |
| RS1458669732 |
PROC
|
Health Risk |
Likely pathogenic |
Reduced protein C activity, Reduced protein C activity |
| RS145867327 |
WARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, mitochondrial |
| RS145867351 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, complementation group K |
| RS145867412 |
GLIS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Monogenic diabetes, Neonatal diabetes mellitus with congenital hypothyroidism |
| RS145867500 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS145867502 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1458677325 |
ANO5
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Gnathodiaphyseal dysplasia |
| RS145867820 |
PRSS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS1458682620 |
LZTR1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 2, Cardiovascular phenotype |
| RS145868557 |
TRIP11
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IA |
| RS145868833 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1458693100 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS145869401 |
PLCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS145869433 |
STARD9
|
Health Risk |
Conflicting classifications of pathogenicity |
STARD9-related disorder, STARD9-related disorder |
| RS1458700065 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease |
| RS145870152 |
CTDP1
|
Health Risk |
Conflicting classifications of pathogenicity |
CTDP1-related disorder, CTDP1-related disorder |
| RS145870742 |
BPTF
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145870973 |
MEGF10
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS145871479 |
NDRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4D |
| RS145871645 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS145871721 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sarcoma, Sarcoma |
| RS145871842 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Nonsyndromic genetic hearing loss |
| RS145872838 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS1458728542 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Q, Epidermolysis bullosa simplex with nail dystrophy |
| RS1458728752 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS1458734302 |
MLH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian cancer, Ovarian cancer |
| RS145873635 |
ASAH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome, ASAH1-related disorders |
| RS145874555 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS145876317 |
CARD14
|
Health Risk |
Conflicting classifications of pathogenicity |
Psoriasis 2, Pityriasis rubra pilaris |
| RS145877597 |
PKD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Polycystic kidney disease 2, PKD2-related disorder |
| RS145877746 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS145878044 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Progressive familial heart block type IB |
| RS145878385 |
CEP250
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, CEP250-related disorder |
| RS1458784088 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1458793437 |
PRPH2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, PRPH2-related disorder |
| RS145879411 |
KIF22
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1458796820 |
CHAT
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS1458799446 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Neoplasm, Sessile serrated polyposis cancer syndrome |
| RS1458799604 |
EDNRB
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 4A, Waardenburg syndrome type 4A |
| RS145879963 |
CXCR4
|
Health Risk |
Conflicting classifications of pathogenicity |
Warts, hypogammaglobulinemia |
| RS1458807270 |
DNM1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 31B |
| RS145880907 |
NFATC3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145881500 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS145881708 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome type 1 |
| RS1458824013 |
ABCA12
|
Health Risk |
Pathogenic |
Lamellar ichthyosis, Lamellar ichthyosis |
| RS1458824689 |
MLC1
|
Health Risk |
Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS145882709 |
PTS
|
Health Risk |
Pathogenic/Likely pathogenic |
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency, 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
| RS145882956 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS145882968 |
SZT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Inborn genetic diseases |
| RS1458831101 |
CLCN2
|
Health Risk |
Likely pathogenic |
Epilepsy, idiopathic generalized |
| RS145883811 |
PROP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pituitary hormone deficiency, combined |
| RS145884404 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS145884431 |
FTO
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal polymalformative syndrome, Boissel type |
| RS145884847 |
INSR
|
Health Risk |
Conflicting classifications of pathogenicity |
Rabson-Mendenhall syndrome, Leprechaunism syndrome |
| RS1458851277 |
SDHA
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Mitochondrial complex II deficiency |
| RS145885540 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS145886270 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia |
| RS145886657 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS145886902 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS145887771 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Inborn genetic diseases |
| RS145888212 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Peroxisome biogenesis disorder |
| RS145888229 |
FOXRED1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 19 |
| RS1458884973 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS145889244 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1458898996 |
HADHA
|
Health Risk |
Pathogenic |
Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency, Mitochondrial trifunctional protein deficiency |
| RS1458900761 |
RAD50
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Nijmegen breakage syndrome-like disorder |
| RS145890213 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS145891116 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
SI-related disorder, Inborn genetic diseases |
| RS145891515 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, FLNB-Related Spectrum Disorders |
| RS1458915316 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS145891535 |
PC
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS145891745 |
VCAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145891813 |
SPTBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS145891889 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS145892183 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1458925593 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1458928910 |
ZEB1
|
Health Risk |
Pathogenic |
Posterior polymorphous corneal dystrophy 3, Posterior polymorphous corneal dystrophy 3 |
| RS1458935187 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS145893756 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, SI-related disorder |
| RS1458938381 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS145893879 |
CHRNB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Inborn genetic diseases |
| RS145894044 |
ALG6
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1458941582 |
ACADVL
|
Health Risk |
Conflicting classifications of pathogenicity |
Very long chain acyl-CoA dehydrogenase deficiency, ACADVL-related disorder |
| RS1458942108 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS145894536 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS145895414 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS145895555 |
SFTPB
|
Health Risk |
Conflicting classifications of pathogenicity |
Surfactant metabolism dysfunction, pulmonary |
| RS1458961443 |
SKIC2
|
Health Risk |
Pathogenic |
— |
| RS145896974 |
RPGRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 13, Leber congenital amaurosis 6 |
| RS145897018 |
ADAMTSL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Geleophysic dysplasia 1, ADAMTSL2-related disorder |
| RS145897390 |
LAMA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1JJ, Cardiovascular phenotype |
| RS145897776 |
DNAJB6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6), Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) |
| RS145897970 |
MAPT
|
Health Risk |
Conflicting classifications of pathogenicity |
Frontotemporal dementia, Frontotemporal dementia |
| RS145898158 |
TECTA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 21, Autosomal dominant nonsyndromic hearing loss 12 |
| RS145899319 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, OTOF-related disorder |
| RS145899609 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS145899734 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS145899844 |
PEX14
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, complementation group K |
| RS145900411 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |